| Literature DB >> 35370011 |
Criseida Torres-Vargas1, José Legorreta-Soberanis2, Belén Madeline Sánchez-Gervacio2, Pablo Alberto Fernández-López1, Miguel Flores-Moreno2, Víctor Manuel Alvarado-Castro2, Sergio Paredes-Solís3, Neil Andersson4, Anne Cockcroft5.
Abstract
BACKGROUND: The Radiographic Assessment of Lung Edema (RALE) score has been used to estimate the extent of pulmonary damage in patients with acute respiratory distress syndrome and might be useful in patients with COVID-19. AIM OF THE STUDY: To examine factors associated with the need for mechanical ventilation in hospitalized patients with a clinical diagnosis of COVID-19, and to estimate the predictive value of the RALE score.Entities:
Keywords: COVID-19; Chest radiograph; Mechanical ventilation; RALE; ROC curves; SARS-CoV-2
Mesh:
Year: 2022 PMID: 35370011 PMCID: PMC8938260 DOI: 10.1016/j.arcmed.2022.03.006
Source DB: PubMed Journal: Arch Med Res ISSN: 0188-4409 Impact factor: 8.323
Figure 1Examples of RALE evaluation of chest X-rays. A. Normal chest X-ray. RALE evaluation 0 points B. Highly suspicious lesions of Covid-19, basal pulmonary opacity with a reticular or linear interstitial pattern and halo sign. Mild RALE evaluation (1–2 points). C. Common pattern of Covid-19, predominance of ground glass image with slight interstitial linear thickening. Moderate RALE evaluation (3–5 points). D. Typical findings of Covid-19, extensive bilateral involvement, mixed ground glass pattern, nodular reticulum, and areas of consolidation. Severe RALE evaluation (≥6 points).
Comorbidities distribution in patients with a clinical diagnosis of COVID-19
| Comorbidities | Female | Male | |
|---|---|---|---|
| High blood pressure (HBP) | 46% (32/69) | 46% (55/120) | 0.99 |
| Type 2 diabetes mellitus (DM2) | 52% (36/69) | 36% (43/120) | 0.04 |
| Obesity | 15% (10/69) | 13% (16/120) | 0.99 |
| Chronic kidney disease (CKD) | 13% (9/69) | 11% (13/120) | 0.82 |
| Chronic obstructive pulmonary disease (COPD) | 4% (3/69) | 7% (8/120) | 0.74 |
| Heart failure (HF) | 7% (5/69) | 3% (3/120) | 0.24 |
| Asthma | 3% (2/69) | 0.8% (1/120) | 0.60 |
| Liver failure | 1% (1/69) | 0.8% (1/120) | 0.99 |
Period between onset of COVID-19 symptoms and RALE evaluation among adult patients only
| Punctuation RALE | First week | Second week | Third week | Fourth week |
|---|---|---|---|---|
| 1–2 points | 5.4% (6/112) | 11.7% (7/60) | 18.2% (2/11) | 0% (0/3) |
| 3–6 points | 41.1% (46/112) | 50.0% (30/60) | 27.3% (3/11) | 0% (0/3) |
| 7–8 points | 53.6% (60/112) | 38.3% (23/60) | 54.5% (6/11) | 100% (3/3) |
XTrend test = 40.36, 6 fd, p <0.00001.
Figure 2Receiver Operating Characteristic (ROC) curve on sensitivity and specificity of RALE evaluation for predicting requirement of mechanical ventilation among patients with clinical diagnosis of COVID-19.
Bivariate analysis of factors associated with the requirement for mechanical ventilation
| Factor | Patients requiring mechanical ventilation | ORna | 95%CI |
|---|---|---|---|
| Sex | |||
| Female | 42.0% (29/69) | 0.68 | 0.37–1.23 |
| Male | 51.7% (61/118) | ||
| Age | |||
| ≥50 years old | 57.4% (74/129) | 3.53 | 1.83–6.82 |
| <50 years old | 27.6% (16/58) | ||
| Type 2 diabetes mellitus (DM2) | |||
| With DM2 | 49.4% (39/79) | 1.09 | 0.61 - 1.95 |
| Without DM2 | 47.2% (51/108) | ||
| High blood pressure (HBP) | |||
| With HBP | 55.2% (48/87) | 1.70 | 0.95–3.03 |
| Without HBP | 42.0% (42/100) | ||
| Obesity | |||
| With obesity | 46.2% (12/26) | 0.91 | 0.40–2.10 |
| Without obesity | 48.4% (78/161) | ||
| Chronic kidney disease (CKD) | |||
| With CKD | 77.3% (17/22) | 4.28 | 1.61–11.44 |
| Without CKD | 44.2% (73/165) | ||
| Chronic obstructive pulmonary disease (COPD) | |||
| With COPD | 63.6% (7/11) | 1.96 | 0.56–6.82 |
| Without COPD | 47.4% (83/176) | ||
| Asthma | |||
| With asthma | 66.7% (2/3) | 2.18 | 0.20–23.26 |
| Without asthma | 47.8% (88/184) | ||
| Liver failure (LF) | |||
| With LF | 50.0% (1/2) | 1.08 | 0.07–17.63 |
| Without LF | 48.1% (89/185) | ||
| Heart failure (HF) | |||
| With HF | 50.0% (4/8) | 1.08 | 0.26–4.47 |
| Without HF | 48.0% (86/179) | ||
| Clasification of Radiographic Assessment Lung Edema (RALE) | |||
| ≥6 points | 60.4% (55/ 91) | 2.66 | 1.48–4.79 |
| <6 points | 36.5% (35/96) | ||
| C-reactive protein | |||
| Positive | 50.0% (75/150) | 1.47 | 0.71–3.04 |
| Negative | 40.5% (15/37) | ||
| Days of hospitalization | |||
| ≥9 d | 51.6% (48/93) | 1.32 | 0.74–2.35 |
| <9 d | 44.7% (42/94) | ||
| Days elapsed from onset illness to admission | |||
| ≥15 d | 54.0% (47/87) | 1.56 | 0.87–2.78 |
| <15 d | 43.0% (43/100) |
Unadjusted Odds Ratio
95% Confidence Intervals.
Final model of the multivariate analysis of factors associated with requiring mechanical ventilation
| Factors | ORna | ORa | 95%CI | ||
|---|---|---|---|---|---|
| Chronic kidney disease | 4.28 | 4.76 | 1.77 - 12.82 | 9.53 | 0.76 |
| ≥50 years old | 3.53 | 3.51 | 1.73 – 7.13 | 12.08 | 0.83 |
| RALE evaluation ≥6 points | 2.66 | 2.27 | 1.22 – 4.22 | 6.63 | 0.99 |
Non-adjusted Odds Ratio
Adjusted Odds Ratio
95% Confidence Interval
X heterogeneity test
p value